Cargando…

A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity

Carcinoembryonic antigen (CEA, CEACAM5, and CD66e) has been found to be associated with various types of cancers, particularly colorectal carcinoma, and developed to be a molecular target for cancer diagnosis and therapy. In present study, we generated a novel anti-CEACAM5 monoclonal antibody, namel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Chaogu, Feng, Jing, Lu, Di, Wang, Ping, Xing, Shu, Coll, Jean-Luc, Yang, Dongling, Yan, Xiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120848/ https://www.ncbi.nlm.nih.gov/pubmed/21731662 http://dx.doi.org/10.1371/journal.pone.0021146

Ejemplares similares

Characterization of murine CEACAM1 in vivo reveals low expression on CD8(+) T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1
por: McLeod, Robbie L., et al.
Publicado: (2018)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
por: Gong, Ying, et al.
Publicado: (2021)

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model
por: Takasago, Takeshi, et al.
Publicado: (2023)

Human Tumor Growth Suppression by Apoptosis Induced with Anti‐ErbB‐2 Chimeric Monoclonal Antibody
por: Sasaki, Shigeru, et al.
Publicado: (1998)

Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma
por: Chiu, Yi-Shu, et al.
Publicado: (2017)

Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
por: Li, Hong, et al.
Publicado: (2018)

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity
por: Prendergast, Jillian M., et al.
Publicado: (2017)

Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
por: Tanaka, Manami, et al.
Publicado: (2022)

Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody
por: Hernández, Jose Luis, et al.
Publicado: (2013)

Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development
por: Desselle, Ariane, et al.
Publicado: (2012)

Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
por: Françoso, Alex, et al.
Publicado: (2017)

Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC(hum) mice
por: Zeitelhofer, Manuel, et al.
Publicado: (2018)

Generation of a monoclonal antibody recognizing the CEACAM glycan structure and inhibiting adhesion using cancer tissue-originated spheroid as an antigen
por: Sato, Yumi, et al.
Publicado: (2016)

Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice
por: Li, Yuzhen, et al.
Publicado: (2022)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Stromal CEACAM1 expression regulates colorectal cancer metastasis
por: Arabzadeh, Azadeh, et al.
Publicado: (2012)

Effect of CEACAM-1 knockdown in human colorectal cancer cells
por: Han, Zhong-Min, et al.
Publicado: (2018)

Preparation of Mouse Monoclonal Antibody for RB1CC1 and Its Clinical Application
por: Hama, Yusuke, et al.
Publicado: (2012)

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis
por: Zhang, Hui, et al.
Publicado: (2013)

Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies
por: Wu, Shang-Jung, et al.
Publicado: (2021)

Corrigendum: Generation of a monoclonal antibody recognizing the CEACAM glycan structure and inhibiting adhesion using cancer tissue-originated spheroid as an antigen
por: Sato, Yumi, et al.
Publicado: (2016)

Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy
por: Molgora, Martina, et al.
Publicado: (2021)

FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis
por: Li, Qingguo, et al.
Publicado: (2018)

Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
por: Wu, Hao-Tian, et al.
Publicado: (2022)

Arrested development: suppression of NK cell function in the tumor microenvironment
por: Riggan, Luke, et al.
Publicado: (2021)

Tumor and Endothelial Cell-Derived Microvesicles Carry Distinct CEACAMs and Influence T-Cell Behavior
por: Muturi, Harrison T., et al.
Publicado: (2013)

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
por: Morales-Estevez, Cristina, et al.
Publicado: (2016)

Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
por: Zhang, Rongsheng, et al.
Publicado: (2019)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC
por: He, Yayi, et al.
Publicado: (2018)

Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma
por: Helfrich, Iris, et al.
Publicado: (2019)

Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis, Andrea M, et al.
Publicado: (2012)

Tumor Targeting by Monoclonal Antibody Functionalized Magnetic Nanoparticles
por: Oltolina, Francesca, et al.
Publicado: (2019)

CD16(+)NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice
por: Williams, Brent A., et al.
Publicado: (2018)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
por: Ceran, Ceyhan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1ddilb6c6064bt080eag28vcau